Cardiac Biomarkers

Cardiac markers are dignified biomarkers to measure cardiac function. They are often discussed in the context of myocardial infarction, but other conditions can lead to an elevation in the level of cardiac marker. Cardiac biomarkers are fundamentals that are released into the blood when the heart is injured or anxious. Cardiac marker is used in the identification and hazard stratification of patients with chest pain and suspected acute coronary syndrome (ACS). These markers include enzymes, hormones and proteins. Cardiac biomarkers have developed as important tools in cardiology in the last 50 years, that is, for primary and secondary prevention, the diagnosis and treatment of acute myocardial infarction (AMI), and the diagnosis and stratification of the risk of heart failure. 

  • Circulatory Biomarker
  • Biomarkers for Heart Failure & Acute Coronary Syndrome
  • Biomarkers for Metabolic Syndrome & Cardiovascular Risk
  • Machine learning & Internet of Things (IoT) application in Digital Biomarkers

Related Conference of Cardiac Biomarkers

January 28-29, 2019

10th Asia Pacific Congress on Polymer Science and Engineering

Courtyard by Marriott Seoul Times Square,Seoul, South Korea
February 18-20, 2019

16th Annual Congress on

Materials Research and Technology

Amsterdam, Netherlands
March 11-12, 2019

5th Annual Conference on Biomaterials

Nice, France
April 24-25, 2019

World Congress on Nanomaterials and Nanotechnology

Budapest | Hungary
May 27-28,2019 |

21st World Congress on Materials Science and Engineering

Four Points by Sheraton | Taipei,Taiwan
July 22-23, 2019

35th World Congress on Materials Science and Nanotechnology

Mercure Albert Park, Melbourne, Australia
August 19-20, 2019,

23rd International Conference on Advanced Materials & Nanotechnology

Radisson Hotel Narita, Tokyo, Japan

Cardiac Biomarkers Conference Speakers

Recommended Sessions

Related Journals

Are you interested in